Skip to main content

Table 1 Baseline characteristics before initiation of extracorporeal membrane oxygenation (ECMO)

From: Risk factors for complete recovery of adults after weaning from veno-venous extracorporeal membrane oxygenation for severe acute respiratory failure: an analysis from adult patients in the Extracorporeal Life Support Organization registry

Variables

CR (n = 1976)

PR (n = 3885)

p

Male

1057 (57.3)

2336 (60.9)

0.009

Age

42.3 ± 15.2

45.9 ± 14.7

< 0.001

Weight

85.9 ± 27.1

91.6 ± 29.2

< 0.001

Primary diagnosis

  

< 0.001

 Bacterial pneumonia

38 (1.9)

117 (3.0)

 

 Viral pneumonia

357 (18.1)

1004 (25.8)

 

 COPD/asthma

123 (6.2)

208 (5.4)

 

 Interstitial lung disease

174 (8.8)

122 (3.1)

 

 Trauma and burn

113 (5.7)

218 (5.6)

 

 ARDS

656 (33.2)

1145 (29.5)

 

 Aspiration pneumonitis

15 (0.8)

32 (0.8)

 

 Sepsis

29 (1.5)

69 (1.8)

 

 Others

471 (23.8)

970 (25.0)

 

Ventilator before ECMO

 PIP

35.1 ± 10.8

34.2 ± 9.1

0.017

 PEEP

13.0 ± 5.5

13.1 ± 5.7

0.674

PaO2 FiO2 ratio

90.8 ± 107.5

75.7 ± 188.9

0.005

 Mean ABP

74.7 ± 19.2

72.2 ± 16.9

< 0.001

 Cardiac arrest before ECMO

111 (5.6)

273 (7.0)

0.039

 RRT

38 (1.9)

213 (5.5)

< 0.001

 Vasopressor

447 (22.6)

1186 (30.5)

< 0.001

 Rescue therapy before ECMO

 Systemic steroids

158 (8.0)

345 (8.9)

0.253

 NO inhalation

218 (11.0)

359 (9.2)

0.030

 NMB agents

572 (28.9)

1254 (32.3)

0.009

  1. Values are expressed as mean ± standard deviation or n (%)
  2. COPD chronic obstructive pulmonary disease, ARDS acute respiratory distress syndrome; ECMO extracorporeal membrane oxygenation, PIP peak inspiratory pressure, PEEP positive end expiratory pressure, ABP arterial blood pressure, RRT renal replacement therapy, NO nitric oxide, NMB neuromuscular blockade